In this report, Global Hyaluronic Acid Viscosupplementation Market is segmented by course of Treatment and Anatomy. The treatment of Osteoarthritis can be done by Single Injection or Multiple Injections of hyaluronic acid into the joints. The market on basis of anatomy can be divided by Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis and Shoulder Osteoarthritis.
The market is also analyzed based on geographic regions which are grouped into Americas, Asia-Pacific (APAC), Europe as well as RoW regions. Osteoarthritis constitutes to be a growing public health problem. This disease is commonly found among adults in the U.S. Thus, the U.S. is leading in providing viscosupplementation treatment. In APAC, the market is forecast to grow since some countries like India possess high number of knee-osteoarthritis patients. Europe is the next leading region for this market. Since, there are no reimbursements in European countries such as Spain, France and other countries; the market in this region is still low.
The major companies of Hyaluronic Acid Viscosupplementation Market are:
Fidia Pharma USA Inc. (U.S),
Ferring Pharmaceuticals Inc. (Switzerland),
Mylan Inc. (U.S),
Zimmer Inc. (U.S.) and many others.
The data is obtained by help of primary and secondary sources. Many questionnaires and interviews were conducted with the key companies of this market to estimate the market values. Secondary sources such as articles and medical journals were study to have an overview of the market. Public health data has been collected from some organization such as World Health Organization that helped to analyze the entire market.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Hyaluronic Acid Viscosupplementation Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Hyaluronic Acid Viscosupplementation Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Hyaluronic Acid Viscosupplementation Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Life Cycle Analysis
5.4. Pricing Analysis
6. Hyaluronic Acid Viscosupplementation Market- By Course of Treatment
6.1. By Single Injection
6.2. By Multiple Injections
7. Hyaluronic Acid Viscosupplementation Market- By Anatomy
7.1. Knee Osteoarthritis
7.2. Hip Osteoarthritis
7.3. Ankle Ostereoarthritis
7.4. Shoulder Osteoarthritis
8. Hyaluronic Acid Viscosupplementation Market- Geographic Analysis
8.4.4. South Korea
9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio)
10.2. Fidia Farma USA Inc.
10.3. Anika Therapeutics, Inc.
10.4. Synvisc –One
10.6. Zimmer, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"